Sign in
Taking people in United StatesPhase 1

Donor stem cell infusion for Crohn's disease or ulcerative colitis

Tests donor stem cells given into a vein in people with inflammatory bowel disease.

Key facts

Who runs it
The Foundation for Orthopaedics and Regenerative Medicine
Where
Naples, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Registry title
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Crohn's Disease or Ulcerative Colitis
Status
Recruiting
Phase
Phase 1
People taking part
15 people, planned
Started
11 Jun 2022
Expected to end
Oct 2028
Type of study
Interventional
Treatments tested
  • cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells
Record updated
20 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with Crohn's disease or ulcerative colitis. It tests the safety of stem cells given through a vein.

Sex
All sexes can join.
Disease stage
A diagnosis of Crohn's disease or ulcerative colitis.

Main reasons for not taking part

  • Active infection
  • Active cancer
  • Chronic failure of several organs
  • Pregnancy
  • Previous organ transplant

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Diagnosis of Crohn's disease or Ulcerative Colitis
  • Understanding and willingness to sign a written informed consent document

Who cannot take part

  • Continued drug abuse
  • Previous organ transplant
  • Active infection
  • Active cancer
  • Chronic multisystem organ failure
  • Medical condition that would (based on the opinion of the investigator) compromise patient's safety
  • Hypersensitivity to sulfur
  • Clinically significant Abnormalities on pre-treatment laboratory evaluation
  • Pregnancy
  • Pre-menopausal women not using contraception

Where in United States

Also in 1 other country, 1 site

  • Prodromos Stem Cell InstituteNaples, United StatesContact: Chadwick Prodromos, MDTaking people

About the trial

What the trial wants to find out

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells for the treatment of Crohn's Disease or Ulcerative Colitis

The group in the trial

  • Treatment GroupTreatment being tested

    Single intravenous infusion

    Treatment: cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Crohn's Disease or Ulcerative Colitis
Plain-language title
Donor stem cell infusion for Crohn's disease or ulcerative colitisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
20 October 2026